1. Home
  2. ALT vs AREN Comparison

ALT vs AREN Comparison

Compare ALT & AREN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • AREN
  • Stock Information
  • Founded
  • ALT 1997
  • AREN 2016
  • Country
  • ALT United States
  • AREN United States
  • Employees
  • ALT N/A
  • AREN N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • AREN Medical/Dental Instruments
  • Sector
  • ALT Health Care
  • AREN Health Care
  • Exchange
  • ALT Nasdaq
  • AREN Nasdaq
  • Market Cap
  • ALT 292.8M
  • AREN 305.8M
  • IPO Year
  • ALT N/A
  • AREN N/A
  • Fundamental
  • Price
  • ALT $3.61
  • AREN $6.52
  • Analyst Decision
  • ALT Strong Buy
  • AREN Strong Buy
  • Analyst Count
  • ALT 6
  • AREN 1
  • Target Price
  • ALT $18.20
  • AREN $10.00
  • AVG Volume (30 Days)
  • ALT 3.5M
  • AREN 176.0K
  • Earning Date
  • ALT 08-15-2025
  • AREN 08-18-2025
  • Dividend Yield
  • ALT N/A
  • AREN N/A
  • EPS Growth
  • ALT N/A
  • AREN N/A
  • EPS
  • ALT N/A
  • AREN 0.16
  • Revenue
  • ALT $20,000.00
  • AREN $128,781,000.00
  • Revenue This Year
  • ALT N/A
  • AREN $31.49
  • Revenue Next Year
  • ALT $346,228.97
  • AREN $10.00
  • P/E Ratio
  • ALT N/A
  • AREN $30.46
  • Revenue Growth
  • ALT N/A
  • AREN N/A
  • 52 Week Low
  • ALT $2.90
  • AREN $0.56
  • 52 Week High
  • ALT $11.16
  • AREN $10.05
  • Technical
  • Relative Strength Index (RSI)
  • ALT 34.75
  • AREN 57.90
  • Support Level
  • ALT $3.58
  • AREN $5.81
  • Resistance Level
  • ALT $4.39
  • AREN $7.02
  • Average True Range (ATR)
  • ALT 0.19
  • AREN 0.53
  • MACD
  • ALT -0.00
  • AREN 0.06
  • Stochastic Oscillator
  • ALT 4.65
  • AREN 78.65

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About AREN The Arena Group Holdings Inc.

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.

Share on Social Networks: